This research aimed to validate this hypothesis by focusing on the novel regulatory relationship between RUNX1 and MUC13, investigating the impact of manipulating their gene expression on CRC malignancy in both in vivo and in vitro models, and assessing the resultant activity changes in the Wnt signaling pathway. Here, MUC13 is linked to colorectal carcinoma.